Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas

Experimental and Molecular Pathology

Volumn 90, Issue 2, 2011, Pages 201-209

  Kim, Hyunki ^a   Eun j, Jung Woo ^b   Lee, Hanna ^a   Nam, Suk Woo ^b   Rhee, Hwanseok ^a   Koh, Kwi Hye ^c   Kim, Hoguen ^a  

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Gastric adenoma; Gastric carcinoma; Hydroxyprostaglandin dehydrogenase 15; Oligonucleotide microarray; Trefoil factor

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; GENE PRODUCT; TREFOIL FACTOR 2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; FOLLISTATIN LIKE 1 TREFOIL FACTOR 1 GENE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYPROSTAGLANDIN DEHYDROGENASE 15 GENE; MALE; PROTEIN EXPRESSION; STOMACH ADENOMA; STOMACH CARCINOMA; STOMACH MUCOSA; STOMACH TUMOR; TREFOIL FACTOR 2 GENE; UPREGULATION;

ADENOMA; AGED; AGED, 80 AND OVER; CARCINOMA; CLUSTER ANALYSIS; DOWN-REGULATION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UP-REGULATION;

LOTUS;

EID: 78651259870     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.12.004     Document Type: Article

References (32)

1. Boussioutas A., et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 2003, 63:2569-2577.
2. Carvalho R., et al. Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab. Invest. 2002, 82:1319-1326.
3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992, 52:6735-6740.
4. DeRisi J.L., et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997, 278:680-686.
5. Ding Y., et al. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Carcinogenesis 2005, 26:65-72.
6. Emami S., et al. Trefoil factor family (TFF) peptides and cancer progression. Peptides 2004, 25:885-898.
7. Hasegawa S., et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23, 040 genes. Cancer Res. 2002, 62:7012-7017.
8. Hippo Y., et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002, 62:233-240.
9. Inoue H., et al. Prognostic score of gastric cancer determined by cDNA microarray. Clin. Cancer Res. 2002, 8:3475-3479.
10. Jang T.J., et al. Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas. Yonsei Med. J. 2008, 49:917-922.
11. Jinawath N., et al. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 2004, 23:6830-6844.
12. Jorgensen K.H., et al. Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul. Pept. 1982, 3:207-219.
13. Kjellev S. The trefoil factor family-small peptides with multiple functionalities. Cell. Mol. Life Sci. 2009, 66:1350-1369.
14. Lee C.H., et al. Gene expression profiling reveals sequential changes in gastric tubular adenoma and carcinoma in situ. World J. Gastroenterol. 2005, 11:1937-1945.
15. Lefebvre O., et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996, 274:259-262.
16. Liu L.X., et al. Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. World J. Gastroenterol. 2002, 8:580-585.
17. Meireles S.I., et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res. 2004, 64:1255-1265.
18. Myung S.J., et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc. Natl Acad. Sci. USA 2006, 103:12098-12102.
19. Oien K.A., et al. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 2003, 22:4287-4300.
20. Oue N., et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 2004, 64:2397-2405.
21. Park W.S., et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000, 119:691-698.
22. Parkin D.M., et al. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
23. Statnikov A., et al. A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics 2005, 21:631-643.
24. Statnikov A., et al. GEMS: a system for automated cancer diagnosis and biomarker discovery from microarray gene expression data. Int. J. Med. Inform. 2005, 74:491-503.
25. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci. Publ. 2004, 327-349.
26. Takenawa H., et al. Differential gene-expression profiles associated with gastric adenoma. Br. J. Cancer 2004, 90:216-223.
27. Tatsuwaki H., et al. Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma. Cancer Sci. 2010, 101:550-558.
28. Thim L. Trefoil peptides: from structure to function. Cell. Mol. Life Sci. 1997, 53:888-903.
29. Thim L., May F.E. Structure of mammalian trefoil factors and functional insights. Cell. Mol. Life Sci. 2005, 62:2956-2973.
30. Wang D., Dubois R.N. Prostaglandins and cancer. Gut 2006, 55:115-122.
31. Werner M., et al. Gastric adenocarcinoma: pathomorphology and molecular pathology. J. Cancer Res. Clin. Oncol. 2001, 127:207-216.
32. Wolf I., et al. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res. 2006, 66:7818-7823.